Hirano, Takao
Toriyama, Yuichi
Takamura, Yoshihiro
Sugimoto, Masahiko
Nagaoka, Taiji
Sugiura, Yoshimi
Okamoto, Fumiki
Saito, Michiyuki
Noda, Kousuke
Yoshida, Shigeo
Ishibazawa, Akihiro
Sawada, Osamu
Murata, Toshinori
Article History
Received: 12 September 2020
Accepted: 8 February 2021
First Online: 24 February 2021
Competing interests
: Akihiro Ishibazawa is a consultant for and receives research support from Optos and Carl Zeiss Meditec, serves as a consultant for Centervue, and has access to research instruments provided by Heidelberg Engineering, Topcon Medical Systems, Optos, Carl Zeiss Meditec, Nidek, and Centervue. Akihiro Ishibazawa reports lecture fees from Novaltis International AG, Santen Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., and Kowa Pharma, Kousuke Noda reports grants from Novartis Pharma K.K. Masahiko Sugimoto reports personal fees from Novartis Pharma K.K., Bayer, Santen Pharmaceutical Co., Ltd., Senjyu Pharmaceutical Co., Ltd., Kowa Pharma, Daiichi Yakuhin Sangyo, and Wakamoto Pharmaceutical Co., Ltd., Osamu Sawada reports research supports from Novartis Phrama K.K., research support from Alcon, personal fees from Santen, personal fees from Novartis Novartis Phrama K.K., personal fees from Bayer, personal fees from Senju, and personal fees from Kowa. Shigeo Yoshida reports personal fees from Novartis Pharma K.K., grants and personal fees from Bayer, personal fees from Kowa Pharma., personal fees from Wakamoto Pharmaceutical Co., Ltd., grants and personal fees from Senjyu Pharmaceutical Co., Ltd., and grants and personal fees from Santen Pharmaceutical Co., Ltd. Takao Hirano reports personal fees from Novartis Pharma K.K., personal fees from Bayer, and personal fees from Carl Zeiss Meditec. Toshinori Murata reports grants from Bayer during the conduct of the study; personal fees from Novartis Pharma K.K., personal fees from Santen Pharma, personal fees from Bayer, and personal fees from Carl Zeiss Meditec. Yoshihiro Takamura reports personal fees from Novartis Pharma, Bayer, Santen, and Senju. Yuichi Toriyama reports personal fees from Novartis Pharma K.K. and personal fees from Carl Zeiss Meditec. Michiyuki Saito, Fumiki Okamoto, Taiji Nagaoka, and Yoshimi Sugiura declare no potential conflict of interest.